Arbutus Biopharma Corp Increase (Decrease) in Income Taxes Receivable
Arbutus Biopharma Corp (ABUS) reported Increase (Decrease) in Income Taxes Receivable of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInIncomeTaxesReceivable · last filed 2020-03-05
CAD
| Period end | Increase (Decrease) in Income Taxes Receivable 12 month |
|---|---|
| 2012-12-31 | -321.21K CAD 20-F · filed 2013-03-27 |
| 2011-12-31 | -72.55K CAD 20-F · filed 2013-03-27 |
| 2010-12-31 | 123.45K CAD 20-F · filed 2013-03-27 |
| 2009-12-31 | -124.32K CAD 20-F · filed 2012-03-27 |
USD
| Period end | Increase (Decrease) in Income Taxes Receivable 3 month | Increase (Decrease) in Income Taxes Receivable 6 month | Increase (Decrease) in Income Taxes Receivable 9 month | Increase (Decrease) in Income Taxes Receivable 12 month | Increase (Decrease) in Income Taxes Receivable 12 month as first filed |
|---|---|---|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-05 | ||||
| 2019-03-31 | -$98.00K 10-Q · filed 2019-05-06 | -$51.00K derived: sum of 2 quarters · filed 2020-03-05 | -$51.00K derived: sum of 3 quarters · filed 2020-03-05 | -$51.00K derived: sum of 4 quarters · filed 2020-03-05 | |
| 2018-12-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $47.00K derived: sum of 2 quarters · filed 2020-03-05 | $47.00K derived: sum of 3 quarters · filed 2020-03-05 | $49.00K 10-K · filed 2020-03-05 | |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | $2.00K 10-Q · filed 2018-11-07 | $182.00K derived: sum of 4 quarters · filed 2019-05-06 | |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-03 | $2.00K 10-Q · filed 2018-08-03 | $182.00K derived: sum of 3 quarters · filed 2019-05-06 | $182.00K derived: sum of 4 quarters · filed 2019-05-06 | |
| 2018-03-31 | $2.00K 10-Q · filed 2019-05-06 | $182.00K derived: sum of 2 quarters · filed 2019-05-06 | $182.00K derived: sum of 3 quarters · filed 2019-05-06 | -$112.00K derived: sum of 4 quarters · filed 2019-05-06 | |
| 2017-12-31 | $180.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $180.00K derived: sum of 2 quarters · filed 2019-03-07 | -$114.00K derived: sum of 3 quarters · filed 2019-03-07 | $47.00K 10-K · filed 2019-03-07 | |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-07 | -$294.00K derived: sum of 2 quarters · filed 2018-11-07 | -$133.00K 10-Q · filed 2018-11-07 | -$134.00K derived: sum of 4 quarters · filed 2018-11-07 | |
| 2017-06-30 | -$294.00K 10-Q · filed 2018-08-03 | -$279.00K 10-Q · filed 2018-08-03 | -$134.00K derived: sum of 3 quarters · filed 2018-08-03 | -$134.00K derived: sum of 4 quarters · filed 2018-08-03 | |
| 2017-03-31 | $15.00K 10-Q · filed 2018-05-04 | $160.00K derived: sum of 2 quarters · filed 2018-05-04 | $160.00K derived: sum of 3 quarters · filed 2018-05-04 | $62.00K derived: sum of 4 quarters · filed 2018-05-04 | |
| 2016-12-31 | $145.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $145.00K derived: sum of 2 quarters · filed 2018-03-16 | $47.00K derived: sum of 3 quarters · filed 2018-03-16 | $47.00K 10-K · filed 2018-03-16 | |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-02 | -$98.00K derived: sum of 2 quarters · filed 2017-11-02 | -$98.00K 10-Q · filed 2017-11-02 | $90.00K derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-06-30 | -$98.00K 10-Q · filed 2017-08-03 | -$98.00K 10-Q · filed 2017-08-03 | $90.00K derived: sum of 3 quarters · filed 2018-03-16 | $90.00K derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-04 | $188.00K derived: sum of 2 quarters · filed 2018-03-16 | $188.00K derived: sum of 3 quarters · filed 2018-03-16 | $188.00K derived: sum of 4 quarters · filed 2018-03-16 | |
| 2015-12-31 | $188.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $188.00K derived: sum of 2 quarters · filed 2018-03-16 | $188.00K derived: sum of 3 quarters · filed 2018-03-16 | $188.00K 10-K · filed 2018-03-16 | |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-03 | $0.00 derived: sum of 2 quarters · filed 2016-11-03 | $0.00 10-Q · filed 2016-11-03 | ||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-04 | $0.00 10-Q · filed 2016-08-04 | |||
| 2014-12-31 | $52.00K 10-K · filed 2017-03-22 | ||||
| 2013-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | $31.00K 10-K · filed 2016-03-09 | $30.96K 6-K · filed 2014-03-06 | ||
| 2013-09-30 | -$10.00K 10-Q · filed 2014-11-07 | ||||
| 2013-06-30 | -$10.00K 10-Q · filed 2014-11-07 | ||||
| 2012-12-31 | -$323.00K 10-K · filed 2015-03-13 | -$322.85K 6-K · filed 2014-03-06 | |||
| 2011-12-31 | -$71.34K 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |